About Internal medicine in particular diabetology
We aim to characterize the underlying mechanisms that drive the development of (pre)diabetes and its complications and to develop appropriate care by including technological innovations resulting in a personalized approach to reverse the negative impact of (pre)diabetes.
Aims
We aim to:
- Determine the value of technology in people with (pre)diabetes;
- Elucidate the role of innate immunity in the pathophysiology of long-term micro- and macrovascular complications and explore the benefit of anti-inflammatory interventions;
- Disentangle the relationship of obesity with the immune system, predisposing to the development of (pre)diabetes, and study the effect of (non)-pharmacologically-induced weight loss.
Internationally we are also known as
The impacts of (pre)diabetes
Research programs
Programs that are connected to this research group.